Background: Mastocytosis is a clinical condition occurring from birth to adulthood. It mainly involves the skin solely or in association with other organs such as the liver, bone marrow, spleen and lymph nodes. A bimodal distribution presenting in children from birth to 2 years of age and in patients older than 15 is commonly described. Case Information: An eight-year-old male patient presented with macules and papules on the trunk and limbs for 6 months. The rash worsened after bathing and physical activity. Results: The symptoms were compatible with cutaneous mastocytosis and confirmed histologically. Conclusion: Patients with mastocytosis may be asymptomatic or have symptoms due to mast cells degranulation – itch, flush, headache, syncope, gastrointestinal complaints of abdominal pain and diarrhea. Diagnosis of cutaneous mastocytosis is based on clinical morphology of skin lesions, positive Darier`s sign and histological skin lesions stained for tryptase and/or CD117. Therapeutic management involves avoiding triggers, H1-/H2- receptor blockers and symptomatic medications. All patients with cutaneous mastocytosis require regular follow-up examinations.
| Published in | International Journal of Clinical Dermatology (Volume 5, Issue 1) |
| DOI | 10.11648/j.ijcd.20220501.11 |
| Page(s) | 1-5 |
| Creative Commons |
This is an Open Access article, distributed under the terms of the Creative Commons Attribution 4.0 International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution and reproduction in any medium or format, provided the original work is properly cited. |
| Copyright |
Copyright © The Author(s), 2022. Published by Science Publishing Group |
Mastocytosis, Child, Urticaria Pigmentosa, Cutaneous Mastocytosis
| [1] | Silva I, Carvalho S, Pinto P, Machado S, Rosado J. Mastocytosis: a rare case of anaphylaxis in paediatric age and literature review. Allergologia er Immunopathologia. 2008. 36; (3): 154-163. DOI: 10.1016/S0301-0546(08)72541-2. |
| [2] | Barete S. Les mastocytoses. Annales de dermatologie et de vénéréologie. 2014; (141): 698-714. |
| [3] | Lange M, Hartmann K, Carter M, Siebenhaar F, Alvarez-Twose I et al. Molecular Background, Clinical Features and Management of Pediatric Mastocytosis: Int. J. Mol. Sci. 2021; 22: 2586. https://doi.org/10.3390/ijms22052586. |
| [4] | Frieri M, Quershi M. Pediatric Mastocytosis: A Review of the Literature. Pediatr Allergy Immunol Pulmonol. 2013; 26 (4): 175-180. doi: 10.1089/ped.2013.0275. |
| [5] | Bolognia J, Jorizzo J, Schaffer J. Dermatology. Neoplasms of the skin. Mastocytosis. 2012. 3-rd edition. Elsevier. 1994-1998. |
| [6] | Guleva D, Mateev G. Mastocytosis in childhood. Practical Pediatry. 2017. 1. (in Bulgarian). |
| [7] | Sagher F, Even-Paz Z. Mastocytosis and the Mast Cell. Basel, Karger, 1967. 4-7. DOI: 10.1159/000390594. |
| [8] | Yungareva I, Dimitrova J, Ivanova B, Popchristova E, Koleva N, Yordanov T, Kalinova Ts, Tchupetlovska M, Temelkova I, Marina S. Urticaria pigmentosa. A clinical case and review of the literature. MedInfo. 2020.8. (In Bulgarian). |
| [9] | Valent P, Akin C, Metcalfe D. Mastocytosis: 2016 updated WHO classification and novel emerging treatment concepts. Blood. 2017; (129): 1420–1427. doi.org/10.1182/blood-2016-09-731893. |
| [10] | Valent P, Horny H, Escribano L, Longley B, Li C, Schwartz L, et al. Diagnostic criteria and classification of mastocytosis: A consensus proposal. Leuk. Res. 2001; 25: 603–625. DOI: 10.1016/s0145-2126(01)00038-8. |
| [11] | Valent P, Akin C, Gleixner K, Sperr W, Reiter A, et al. Multidisciplinary challenges in mastocytosis and how to address with personalized medicine approaches. Int. J. Mol. Sci. 2019; 20: 1–17. DOI: 10.3390/ijms20122976. |
| [12] | Kettelhut B, Metcalfe D. Mastocytosis. J Invest Dermatol 1991; 96: 115–118. doi.org/10.1111/1523-1747.ep12468942. |
| [13] | Komi DEA, Rambasek T, Wöhrl S. Mastocytosis: From a Molecular Point of View. Clin. Rev. Allergy Immunol. 2018; 54: 397–411. DOI: 10.1007/s12016-017-8619-2. |
| [14] | Wasag B, Niedoszytko M, Piskorz A, Lange M, Renke, J, Jassem E, et al. Novel, activating KIT-N822I mutation in familial cutaneous mastocytosis. Exp. Hematol. 2011. 39, 859–865. doi.org/10.1016/j.exphem.2011.05.009. |
| [15] | Hartmann K, Escribano L, Grattan C, Brockow K, Carter M, et al. Cutaneous manifestations in patients with mastocytosis: Consensus report of the European Competence Network on Mastocytosis; the American Academy of Allergy, Asthma & Immunology; and the European Academy of Allergology and Clinical Immunology. J. Allergy Clin. Immunol. 2016, 137, 35–45. doi: 10.1016/j.jaci.2015.08.034. |
| [16] | Hartmann K, Valent P, Horny H. Cutaneous mastocytosis. In World Health Organization (WHO) Classification of Skin Tumours, 4th ed. Elder D, Massi D, Scolyer R, Willemze R, International Agency for Research on Cancer: Lyon, France. 2018: 275–278. |
| [17] | Castells M, Metcalfe D, Escribano L. Diagnosis and treatment of cutaneous mastocytosis in children: Practical recommendations. Am. J. Clin. Dermatol. 2011, 12, 259–270. doi: 10.2165/11588890-000000000-00000. |
| [18] | Matito A, Azaña J, Torrelo A, Alvarez-Twose I. Cutaneous Mastocytosis in Adults and Children: New Classification and Prognostic Factors. Immunol. Allergy Clin. N. Am. 2018; 38: 351–363. doi: 10.1016/j.iac.2018.04.001. |
| [19] | Brockow K, Akin C, Huber M, Metcalfe D. Assessment of the extent of cutaneous involvement in children and adults with mastocytosis: Relationship to symptomatology, tryptase levels, and bone marrow pathology. J. Am. Acad. Dermatol. 2003; 48: 508–516. doi: 10.1067/mjd.2003.98. |
| [20] | Alvarez-Twose I, Vañó-Galván S, Sánchez-Muñoz L, Morgado J, Matito A, et al. Increased serum baseline tryptase levels and extensive skin involvement are predictors for the severity of mast cell activation episodes in children with mastocytosis. Allergy. 2012; 67: 813–818. doi: 10.1111/j.1398-9995.2012.02812.x. |
| [21] | Valent P, Akin C, Hartmann, K, Nilsson G, Reiter A, et al. Mast cells as a unique hematopoietic lineage and cell system: From Paul Ehrlich’s visions to precision medicine concepts. Theranostics. 2020; 10: 10743–10768. doi: 10.7150/thno.46719. |
| [22] | Lange M, Ługowska-Umer H, Niedoszytko M, Wasag B, Limon J, et al. Diagnosis of Mastocytosis in Children and Adults in Daily Clinical Practice. Acta Dermato-Venereol. 2016, 96, 292–297. |
| [23] | Broesby-Olsen S, Carter M, Kjaer H, Mortz C, Møller M et al. Pediatric Expression of Mast Cell Activation Disorders. Immunol. Allergy Clin. N. Am. 2018; 38: 365–377. doi: 10.1016/j.iac.2018.04.009. |
| [24] | Brockow K, Ring J, Alvarez-Twose I, Orfao A, Escribano, L. Extensive blistering is a predictor for severe complications in children with mastocytosis. Allergy 2012; 67: 1323–1324. doi: 10.1111/all.12013. |
| [25] | Castells M, Butterfield J. Mast cell activation syndrome and mastocytosis: Initial treatment options and long-term management. J. Allergy Clin. Immunol. Pract. 2019; 7: 1097–1106. doi: 10.1016/j.jaip.2019.02.002. |
| [26] | Jenkinson H, Lundgren A, Carter M, Diaz L, Levy M. Management of neonate with diffuse cutaneous mastocytosis: Case report and literature review. Pediatr. Dermatol. 2019; 36: 486–489. DOI: 10.1111/pde.13801. |
| [27] | Matito A, Carter M. Cutaneous and systemic mastocytosis in children: A risk factor for anaphylaxis? Curr Allergy Asthma Rep. 2015; 15: 22. doi: 10.1007/s11882-015-0525-1. |
| [28] | Barnes M, Van L, De Long L, Lawley L. Severity of cutaneous findings predict the presence of systemic symptoms in pediatric maculopapular cutaneous mastocytosis. Pediatr. Dermatol. 2014; 31: 271–275. doi: 10.1111/pde.12291. |
| [29] | Leung AKC, Lam J, Leong K. Childhood Solitary Cutaneous Mastocytoma: Clinical Manifestations, Diagnosis, Evaluation, and Management. Curr. Pediatr. Rev. 2019; 15: 42–46. doi: 10.2174/1573396315666181120163952. |
| [30] | Husain Z, Waterman D, Ellison K, DeSimone J. Management of poorly controlled indolent systemic mastocytosis using narrowband UVB phototherapy. Cutis 2017; 99: 30–33. PMID: 28632811. |
APA Style
Tsveta Kalinova, Valentina Broshtilova, Yoanna Velevska-Vatova, Sonya Marina. (2022). Cutaneous Mastocytosis in an 8-year-old Child: Case Report and Review of the Literature. International Journal of Clinical Dermatology, 5(1), 1-5. https://doi.org/10.11648/j.ijcd.20220501.11
ACS Style
Tsveta Kalinova; Valentina Broshtilova; Yoanna Velevska-Vatova; Sonya Marina. Cutaneous Mastocytosis in an 8-year-old Child: Case Report and Review of the Literature. Int. J. Clin. Dermatol. 2022, 5(1), 1-5. doi: 10.11648/j.ijcd.20220501.11
Share This Article
Twitter
Linked In
Facebook
Copy
Download@article{10.11648/j.ijcd.20220501.11,
author = {Tsveta Kalinova and Valentina Broshtilova and Yoanna Velevska-Vatova and Sonya Marina},
title = {Cutaneous Mastocytosis in an 8-year-old Child: Case Report and Review of the Literature},
journal = {International Journal of Clinical Dermatology},
volume = {5},
number = {1},
pages = {1-5},
doi = {10.11648/j.ijcd.20220501.11},
url = {https://doi.org/10.11648/j.ijcd.20220501.11},
eprint = {https://article.sciencepublishinggroup.com/pdf/10.11648.j.ijcd.20220501.11},
abstract = {Background: Mastocytosis is a clinical condition occurring from birth to adulthood. It mainly involves the skin solely or in association with other organs such as the liver, bone marrow, spleen and lymph nodes. A bimodal distribution presenting in children from birth to 2 years of age and in patients older than 15 is commonly described. Case Information: An eight-year-old male patient presented with macules and papules on the trunk and limbs for 6 months. The rash worsened after bathing and physical activity. Results: The symptoms were compatible with cutaneous mastocytosis and confirmed histologically. Conclusion: Patients with mastocytosis may be asymptomatic or have symptoms due to mast cells degranulation – itch, flush, headache, syncope, gastrointestinal complaints of abdominal pain and diarrhea. Diagnosis of cutaneous mastocytosis is based on clinical morphology of skin lesions, positive Darier`s sign and histological skin lesions stained for tryptase and/or CD117. Therapeutic management involves avoiding triggers, H1-/H2- receptor blockers and symptomatic medications. All patients with cutaneous mastocytosis require regular follow-up examinations.},
year = {2022}
}
TY - JOUR T1 - Cutaneous Mastocytosis in an 8-year-old Child: Case Report and Review of the Literature AU - Tsveta Kalinova AU - Valentina Broshtilova AU - Yoanna Velevska-Vatova AU - Sonya Marina Y1 - 2022/09/14 PY - 2022 N1 - https://doi.org/10.11648/j.ijcd.20220501.11 DO - 10.11648/j.ijcd.20220501.11 T2 - International Journal of Clinical Dermatology JF - International Journal of Clinical Dermatology JO - International Journal of Clinical Dermatology SP - 1 EP - 5 PB - Science Publishing Group SN - 2995-1305 UR - https://doi.org/10.11648/j.ijcd.20220501.11 AB - Background: Mastocytosis is a clinical condition occurring from birth to adulthood. It mainly involves the skin solely or in association with other organs such as the liver, bone marrow, spleen and lymph nodes. A bimodal distribution presenting in children from birth to 2 years of age and in patients older than 15 is commonly described. Case Information: An eight-year-old male patient presented with macules and papules on the trunk and limbs for 6 months. The rash worsened after bathing and physical activity. Results: The symptoms were compatible with cutaneous mastocytosis and confirmed histologically. Conclusion: Patients with mastocytosis may be asymptomatic or have symptoms due to mast cells degranulation – itch, flush, headache, syncope, gastrointestinal complaints of abdominal pain and diarrhea. Diagnosis of cutaneous mastocytosis is based on clinical morphology of skin lesions, positive Darier`s sign and histological skin lesions stained for tryptase and/or CD117. Therapeutic management involves avoiding triggers, H1-/H2- receptor blockers and symptomatic medications. All patients with cutaneous mastocytosis require regular follow-up examinations. VL - 5 IS - 1 ER -
Information
Email: